The evolution of ventricular assist devices and the heartware® ventricular assist system

European Cardiology

Volumn 8, Issue 1, 2012, Pages 32-35

  Hayward, Christopher ^a   Swartz, Marc ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HEARTWARE INC   (United States)

Author keywords

Circulatory support; Heart failure; Heartware; Left ventricular assist device

Indexed keywords

ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; EQUIPMENT DESIGN; GRAFT SURVIVAL; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HUMAN; PATIENT ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; SURVIVAL RATE; VENTRICULAR ASSIST DEVICE;

EID: 84871981956     PISSN: 17583756     EISSN: 17583764     Source Type: Journal    
DOI: 10.15420/ecr.2012.8.1.32     Document Type: Article

References (26)

1. Lund LH, Matthews J, Aaronson K, Patient selection for left ventricular assist devices, Eur J Heart Fail, 2010;12:434-43
2. Lloyd-Jones D, Adams RJ, Brown TM, et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2010 update: a report from the American Heart Association, Circulation, 2010;121;e46-e215.
3. Remme WJ, McMurray JJV, Rauch B, et al., Public awareness of heart failure in Europe: first results from SHAPE, Europ Heart J, 2005;26:2413-21.
4. Mosterd A, Hoes AW, de Bruyne MC, et al., Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study, Eur Heart J, 1999;20:447-55.
5. Le Gallois JJC, Experiments on the Principles of Life, Philadelphia, PA: Thomas, 1813 (Translation of: Le Gallois JJC, Expériences sur le Principe de la Vie, Paris, 2812)
6. Pae WE Jr, Rosenberg G, Donachy JH, et al., Mechanical circulatory assistance for postoperative cardiogenic shock: a three year experience, Trans Am Soc Artif Intern Organs, 1980;26:256-61.
7. Pennington DG, Merjavy JP, Swartz MT, et al., The importance of biventricular failure in patients with postoperative cardiogenic shock, Ann Thorac Surg, 1985;39:16-26.
8. Miller CA, Pae WE Jr, Pierce WS, Combined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in conjunction with heart transplantation: fourth official report-1989, J Heart Transplant, 1990;9:453
9. Pennington DG, McBride LR, Swartz MT, et al., Use of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operations, Ann Thorac Surg, 1989;47:130-5.
10. Frazier OH, Rose EA, Oz MC, et al., Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation, J Thorac Cardiovasc Surg, 2001;122:1186-95.
11. El-Banayosy A, Deng M, Loisance DY, et al., The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study, Eur J Cardiothorac Surg, 1999;15:835-41.
12. Farrar DJ, Hill JD, Gray LA Jr, et al., Heterotopic prosthetic ventricles as a bridge to cardiac transplantation. A multicenter study in 29 patients, N Engl J Med, 1988;318:333-40.
13. Slaughter MS, Tsui SS, El-Banayosy A, et al., IVAD Study Group, Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device, J Thorac Cardiovasc Surg, 2007;133:1573-80.
14. Rose EA, Gelijns AC, Moskowitz AJ, et al., Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group, Longterm use of a left ventricular assist device for end-stage heart failure, N Engl J Med, 2001;345:1435-43.
15. Goldstein DJ, Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation, Circulation, 2003;108(Suppl. 1):II272-7.
16. Frazier OH, Myers TJ, Gregoric ID, et al., Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system, Circulation, 2002;105:2855.
17. Dickstein K, Vardas PE, Auricchio A, et al., 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association, Eur Heart J, 2010;31:2677-87.
18. Miller LW, Pagani FD, Russell SD, et al., HeartMate II Clinical Investigators, Use of a continuous-flow device in patients awaiting heart transplantation, N Engl J Med, 2007;357:885-96.
19. Pagani FD, Miller LW, Russell SD, Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device, J Am Coll Cardiol, 2009;54:322-4
20. Slaughter MS, Rogers JG, Milano CA, et al., Advanced heart failure treated with continuous-flow left ventricular assist device, N Engl J Med, 2009;361:2241-51.
21. Pamboukian SV, Mechanical circulatory support: we are halfway there, J Am Coll Cardiol, 2011;57:1383-5
22. Strueber M, O'Driscoll G, Jansz P, et al., Multicenter evaluation of an intrapericardial left ventricular assist system, J Am Coll Cardiol, 2011;57:1375-82.
23. LaRose J, Tamez D, Ashenuga M, Reyes C, Design concepts and principle of operation of the HeartWare ventricular assist system, ASAIO J, 2010;56:285-9
24. Slaughter MS, Ising MS, Tamez D, et al., Increase in circadian variation after continuous-flow ventricular assist device implantation, J Heart Lung Transplant, 2010;29:695-7.
25. Carder C, Quantification of Ambulatory Power Source for Ventricular Assist System, Presented at: American Society of Artificial Internal Organs Annual Meeting, Baltimore, MD, 29 May 2010
26. Aaronson K, Slaughter M, McGee E, et al., Evaluation of the HeartWare HVAD Left Ventricular Assist System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge to Transplant Trial, Presented at: American Heart Association Scientific Sessions, Chicago, IL, 14 November 2010.